Evommune(EVMN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EVMN Evommune

盘后交易 08-14 19:56:58 EDT

14.65

+0.58

+4.12%

盘后14.71

+0.06+0.39%

19:34 EDT

最高14.68	最低13.94	成交量36.26万
今开13.94	昨收14.07	日振幅5.26%
总市值5.32亿	流通市值2.93亿	总股本3,629万
成交额521.74万	换手率1.81%	流通股本1,998万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EVMN","market":"US","secType":"STK","nameCN":"Evommune","latestPrice":14.65,"timestamp":1786737600000,"preClose":14.07,"halted":0,"volume":362586,"hourTrading":{"tag":"盘后","latestPrice":14.7072,"preClose":14.65,"latestTime":"19:34 EDT","volume":687,"amount":10038.463923,"timestamp":1786750446434,"change":0.0572,"changeRate":0.003904,"amplitude":0.032573},"delay":0,"changeRate":0.0412224591329069,"floatShares":19982000,"shares":36292113,"eps":-2.609,"marketStatus":"盘后交易","change":0.58,"latestTime":"08-14 19:56:58 EDT","open":13.94,"high":14.68,"low":13.94,"amount":5217373.958412,"amplitude":0.052594,"askPrice":15.96,"askSize":100,"bidPrice":12.03,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.609,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1786752000000},"marketStatusCode":4,"adr":0,"listingDate":1762405200000,"exchange":"NYSE","adjPreClose":14.07,"preHourTrading":{"tag":"盘前","latestPrice":14.6059,"preClose":14.07,"latestTime":"09:29 EDT","volume":267,"amount":3724.855857,"timestamp":1786714181883,"change":0.5359,"changeRate":0.038088,"amplitude":0.210377},"postHourTrading":{"tag":"盘后","latestPrice":14.7072,"preClose":14.65,"latestTime":"19:34 EDT","volume":687,"amount":10038.463923,"timestamp":1786750446434,"change":0.0572,"changeRate":0.003904,"amplitude":0.032573},"volumeRatio":0.890046,"impliedVol":1.2,"impliedVolPercentile":0.5316},"requestUrl":"/m/hq/s/EVMN/wiki","defaultTab":"wiki","newsList":[{"id":"1180323615","title":"Evommune公布Evo756针对中重度慢性自发性荨麻疹的2b期试验顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1180323615","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180323615?lang=zh_cn&edition=full","pubTime":"2026-06-29 20:30","pubTimestamp":1782736249,"startTime":"0","endTime":"0","summary":"Evommune公司宣布了其候选药物Evo756在中重度慢性自发性荨麻疹患者中进行的2b期临床试验的顶线结果。该试验旨在评估Evo756在此类适应症中的疗效与安全性，相关数据为后续临床开发提供了关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149806861","title":"Evommune公司提交招股说明书：现有股东拟转售最多450万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1149806861","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149806861?lang=zh_cn&edition=full","pubTime":"2026-04-18 04:08","pubTimestamp":1776456494,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新备案文件，生物制药公司Evommune已正式提交招股说明书，披露公司现有股东计划转售最多450万股Evommune普通股。\n此次备案文件显示，本次股份转售不涉及公司新发行股份，所有拟出售股份均来自现有股东。该招股说明书的提交标志着股东已获得通过公开市场减持公司股份的资格。\n作为专注于炎症性疾病创新疗法开发的临床阶段生物技术企业，Evommune此次股东股份转售计划受到市场关注。文件未透露具体售股股东身份及股份出售时间安排。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617590756","title":"Evommune, Inc.盘中异动 快速下跌6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617590756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2617590756?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:41","pubTimestamp":1772635288,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日22时41分，Evommune, Inc.股票出现异动，股价大幅下挫6.16%。Evommune, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Klotho Neurosciences, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Klotho Neurosciences, Inc.、Onconetix, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为38.04%、31.92%、23.82%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Edesa Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为28.39%、20.67%、13.00%。Evommune, Inc.公司简介：Evommune Inc 是一家临床阶段的生物技术公司，专注于开发针对慢性炎症性疾病关键驱动因素的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304224128a6a29a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304224128a6a29a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614897402","title":"Evommune, Inc.盘中异动 快速下跌5.11%报25.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614897402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614897402?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:48","pubTimestamp":1772203739,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日22时48分，Evommune, Inc.股票出现波动，股价急速下跌5.11%。截至发稿，该股报25.27美元/股，成交量6.4999万股，换手率0.21%，振幅8.30%。Evommune, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Evommune, Inc.公司简介：Evommune Inc 是一家临床阶段的生物技术公司，专注于开发针对慢性炎症性疾病关键驱动因素的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227224859a7274650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227224859a7274650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612019442","title":"Evommune, Inc.盘中异动 急速下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612019442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2612019442?lang=zh_cn&edition=full","pubTime":"2026-02-18 03:28","pubTimestamp":1771356532,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日03时28分，Evommune, Inc.股票出现异动，股价快速跳水5.23%。Evommune, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Polaryx Therapeutics, Inc.、Cibus, Inc.、Biodexa Pharmaceuticals Plc涨幅较大，Ensysce Biosciences, Inc.、Polaryx Therapeutics, Inc.、Ernexa Therapeutics Inc.较为活跃，换手率分别为810.90%、101.69%、96.36%，振幅较大的相关个股有Polaryx Therapeutics, Inc.、Ensysce Biosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 ，振幅分别为81.33%、74.28%、39.89%。Evommune, Inc.公司简介：Evommune Inc 是一家临床阶段的生物技术公司，专注于开发针对慢性炎症性疾病关键驱动因素的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218032852a4ae1699&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218032852a4ae1699&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evommune.com","stockEarnings":[{"period":"1week","weight":0.0516},{"period":"1month","weight":0.1735},{"period":"3month","weight":-0.3861},{"period":"6month","weight":-0.5543},{"period":"1year","weight":-0.1206},{"period":"ytd","weight":-0.1782}],"compareEarnings":[{"period":"1week","weight":0.0121},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.141},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.1407}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Evommune, Inc.是一家于2020年4月在特拉华州注册成立的公司，总部位于加利福尼亚州的帕洛阿尔托。该公司是一家临床阶段的生物技术公司，专注于针对慢性炎症疾病主要致病因素的创新治疗方案开发。其初步临床开发项目集中在慢性自发性荨麻疹、特应性皮炎和溃疡性结肠炎上。","exchange":"NYSE","name":"Evommune","nameEN":"Evommune"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evommune(EVMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Evommune(EVMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Evommune,EVMN,Evommune股票,Evommune股票老虎,Evommune股票老虎国际,Evommune行情,Evommune股票行情,Evommune股价,Evommune股市,Evommune股票价格,Evommune股票交易,Evommune股票购买,Evommune股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evommune(EVMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Evommune(EVMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}